Lilly is a leader in creating diverse representation in clinical trials to gain insight into making medicines that are effective for all who use them. Lilly has nearly 450 diverse clinical trial sites in the U.S., with more being added constantly.
We’re Not All The Same
As science improves, it has become increasingly clear that there are differences in patients’ responses to medications based on a variety of factors, such as genetics, ethnicities and cultural differences. Minorities also have a disproportionately higher incidence of certain diseases compared to whites. Read more from the Office of Minority Health.